318 related articles for article (PubMed ID: 15606685)
1. Urinary concentration of transforming growth factor-beta-inducible gene-h3(beta ig-h3) in patients with Type 2 diabetes mellitus.
Cha DR; Kim IS; Kang YS; Han SY; Han KH; Shin C; Ji YH; Kim NH
Diabet Med; 2005 Jan; 22(1):14-20. PubMed ID: 15606685
[TBL] [Abstract][Full Text] [Related]
2. Elevation of urinary betaig-h3, transforming growth factor-beta-induced protein in patients with type 2 diabetes and nephropathy.
Ha SW; Kim HJ; Bae JS; Jeong GH; Chung SC; Kim JG; Park SH; Kim YL; Kam S; Kim IS; Kim BW
Diabetes Res Clin Pract; 2004 Aug; 65(2):167-73. PubMed ID: 15223229
[TBL] [Abstract][Full Text] [Related]
3. Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.
Kim NH; Kim KB; Kim DL; Kim SG; Choi KM; Baik SH; Choi DS; Kang YS; Han SY; Han KH; Ji YH; Cha DR
Diabet Med; 2004 Jun; 21(6):545-51. PubMed ID: 15154937
[TBL] [Abstract][Full Text] [Related]
4. Pioglitazone reduces urinary protein and urinary transforming growth factor-beta excretion in patients with type 2 diabetes and overt nephropathy.
Katavetin P; Eiam-Ong S; Suwanwalaikorn S
J Med Assoc Thai; 2006 Feb; 89(2):170-7. PubMed ID: 16579002
[TBL] [Abstract][Full Text] [Related]
5. [Cytokines in noninvasive diagnostics of diabetic nephropathy progression].
Senatorski G; Paczek L; Kropiewnicka E; Bartłomiejczyk I
Pol Merkur Lekarski; 2002 Nov; 13 Suppl 1():28-32. PubMed ID: 12621778
[TBL] [Abstract][Full Text] [Related]
6. Urinary transforming growth factor-beta-induced gene-h3 (betaig-h3) as a sensitive predictor in chronic cyclosporine nephrotoxicity.
Kim CD; Cho YJ; Park SH; Ha SW; Lee EG; Kim YJ; Kwon TH; Kim IS; Kim YL
Transplant Proc; 2006 Jun; 38(5):1314-9. PubMed ID: 16797290
[TBL] [Abstract][Full Text] [Related]
7. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.
Navarro JF; Mora C; Gómez M; Muros M; López-Aguilar C; García J
Nephrol Dial Transplant; 2008 Mar; 23(3):919-26. PubMed ID: 17911088
[TBL] [Abstract][Full Text] [Related]
8. Messenger RNA expression of target genes in the urinary sediment of patients with chronic kidney diseases.
Szeto CC; Chan RW; Lai KB; Szeto CY; Chow KM; Li PK; Lai FM
Nephrol Dial Transplant; 2005 Jan; 20(1):105-13. PubMed ID: 15561743
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus.
Wang QY; Chen FQ
Diabetes Res Clin Pract; 2009 Feb; 83(2):215-9. PubMed ID: 19097668
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta at clinical onset of Type 1 diabetes mellitus. A pilot study.
Flores L; Näf S; Hernáez R; Conget I; Gomis R; Esmatjes E
Diabet Med; 2004 Aug; 21(8):818-22. PubMed ID: 15270783
[TBL] [Abstract][Full Text] [Related]
11. Polymorphism of the aldosterone synthase gene is not associated with progression of diabetic nephropathy, but associated with hypertension in type 2 diabetic patients.
Ko GJ; Kang YS; Lee MH; Song HK; Kim HK; Cha DR
Nephrology (Carlton); 2008 Dec; 13(6):492-9. PubMed ID: 18771471
[TBL] [Abstract][Full Text] [Related]
12. Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients.
Navarro JF; Mora C; Muros M; García J
Nephrol Dial Transplant; 2006 Dec; 21(12):3428-34. PubMed ID: 16935891
[TBL] [Abstract][Full Text] [Related]
13. Factors determining the 24-h blood pressure profile in normotensive patients with type 1 and type 2 diabetes.
Spallone V; Maiello MR; Cicconetti E; Pannone A; Barini A; Gambardella S; Menzinger G
J Hum Hypertens; 2001 Apr; 15(4):239-46. PubMed ID: 11319671
[TBL] [Abstract][Full Text] [Related]
14. Increased renal GLUT1 abundance and urinary TGF-beta 1 in streptozotocin-induced diabetic rats: implications for the development of nephropathy complicating diabetes.
D'Agord Schaan B; Lacchini S; Bertoluci MC; Irigoyen MC; Machado UF; Schmid H
Horm Metab Res; 2001 Nov; 33(11):664-9. PubMed ID: 11733869
[TBL] [Abstract][Full Text] [Related]
15. Acute-phase proteins and microalbuminuria among patients with type 2 diabetes.
Gomes MB; Nogueira VG
Diabetes Res Clin Pract; 2004 Oct; 66(1):31-9. PubMed ID: 15364159
[TBL] [Abstract][Full Text] [Related]
16. [Role of nocturnal blood pressure in the onset of diabetic nephropathy].
Garcia C; Mayaudon H; Bordier L; Le Berre JP; Dupuy O; Bauduceau B
Arch Mal Coeur Vaiss; 2007 Aug; 100(8):668-72. PubMed ID: 17928773
[TBL] [Abstract][Full Text] [Related]
17. Manganese superoxide dismutase gene polymorphism (V16A) is associated with stages of albuminuria in Korean type 2 diabetic patients.
Lee SJ; Choi MG; Kim DS; Kim TW
Metabolism; 2006 Jan; 55(1):1-7. PubMed ID: 16324912
[TBL] [Abstract][Full Text] [Related]
18. The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy.
Shimoike T; Inoguchi T; Umeda F; Nawata H; Kawano K; Ochi H
Metabolism; 2000 Aug; 49(8):1030-5. PubMed ID: 10954022
[TBL] [Abstract][Full Text] [Related]
19. Diurnal changes in urinary excretion of IgG, transferrin, and ceruloplasmin depend on diurnal changes in systemic blood pressure in normotensive, normoalbuminuric type 2 diabetic patients.
Hosoba M; Fujita H; Miura T; Morii T; Shimotomai T; Koshimura J; Yamada Y; Ito S; Narita T
Horm Metab Res; 2009 Dec; 41(12):910-5. PubMed ID: 19670106
[TBL] [Abstract][Full Text] [Related]
20. Increased urinary levels of CXCL5, CXCL8 and CXCL9 in patients with Type 2 diabetic nephropathy.
Higurashi M; Ohya Y; Joh K; Muraguchi M; Nishimura M; Terawaki H; Yagui K; Hashimoto N; Saito Y; Yamada K
J Diabetes Complications; 2009; 23(3):178-84. PubMed ID: 18413205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
